Davies E. F., Avery G. S. Ibuprofen: A review of its pharmacologica 1 properties and therapeutic efficacy in rheumatic disorders. — Drugs, 1971, 2, 416.
Huskisson E. C, Woolf D. L., Balme H. W. et al. Four new anti-inflammatory drugs responses and variations. — Brit. med. J., 1976, 1, 1048.
Ansell B. M., Hanna В., Moran H. et al. Naproxen in juvenile chronic polyarthritis. — Europ. J. Rheumatol. Inflammation, 1979, 2, 79.
Brogden R. N., Pinder R. M., Sawyer Phyllis R. et al. Naproxen: A review of its pharmacological properties and therapeutic efficacy and use. Drugs, 1975, 9, 326.
Hart F. D., Matts S. G. F. Naproxen (Naprosyn) and gastrointestinal haemorrhage. — Brit. med. J., 1974, 2, 51.
Hill H. F., Hill A. G, Mowat A. G. et al. Naproxen. A new non-hormonal antiinflammatory agent. Studies in rheumatoid arthritis. — Annals of the Rheumatic Diseases 1974, 33, 12.
Seifert M. Я., Gumpel J. M., Christie G. A. Naproxen. A new non-hormonal an-ti-inflammatory agent. Studies in rheumatoid arthritis. — Ann. rheumat. Dis., 1974, 33, 12.
Huskisson E. C, Woolf D. L., Balme H. W. et al. Four new anti-inflammatory drugs: responses and variations. — Brit. med. J., 1976, 1, 1048.
Roth S. H., Boost G. An open trial of naproxen in rheumatoid arthritis patients with significant esophageal, gastric and duodenal lesions. — J. clin Pharmacol., 1975, 15, 378.
Segre E. J., Naproxen metabolism in man. — J. clin. Pharmacol., 1975, 15, 316.
Его gen R. N., Pinder R. M., Speight Т. М., Avery G. S. Fenoprofen: A review of its pharmacological properties and therapeutic efficacy in rheumatic diseases. — Drugs, 1977, 13, 241.
Gruber C. M. Jr. Clinical pharmacology of fenoprofen: a review. — J. Rheumatol., 1976, 3 (Suppl. 2), 8.
Huskisson E, C., Wojtulewski J. A., Berry H. et al. Tlreatment of rheumatoid arthritis with fenoprofen. Comparison with aspirin. — Brit med J., 1974, 1, 176.
Huskisson E. C, Woolf D. L., Balme H. W. et al. Four new anti-inflammatory drugs: responses and variations. — Brit. med. J., 1976, 1, 1048.
Huskisson E. C, Woolf D. L., Balme H. W. et al. Four new anti-inflammatory drugs responses and variations. — Brit. med. J., 1976, 1, 1048.
Huskisson Е. С. Clinical studies with benoxaprofen. The story so far. — Eu-rop. J. Rheumatol. Inflammation, 1979, 3, 29.
Ridolfo A. S., Nickander R., Mikulascher W. M. Fenoprofen and benoxaprofen; in Huskisson (Ed.) Clinics in Rheumatic Diseases Vol. 5 Anti-Rheumatic Drugs, p. 395. Saunders, London, 1979.
Brogen R. N., Heel R. C, Speight Т. М., Avery G. S. Flurbiprofen: A review of its pharmacological properties and therapeutic use in rheumatic diseases. — Drugs, 1979, 18, 417.
Symposium on Froben. Current Medical Research and Opinion, 1975, 3 (Suppl. 4).
Brogden R. N., Heel R. C, Speight Т. М., Avery G. S. Fenbufen: a review of its pharmacological properties and therapeutic use in rheumatic diseases and acute pain. — Drugs, 1981, 21, 1.
Chelam F., Репа M., Lizerazo H., Farias B. Comparison of fenbufen and aspirin in the treatment of rheumatoid arthritis. — Curr. Therapeutic Res., 1977, 22, 769.
Cuisinand G., Legheand J., Uorca G. et al. Pharmacokinetics of fenbufen in man. — Europ. J. clin. Pharmacol., 1979, 16, 59.
Brogen R. N., Heel R. C, Speight T. M., Avery G. S. Alclofenac: A review of its pharmacological properties and therapeutic efficacy in rheumatoid arthritis and allied rheumatic disorders. — Drugs, 1977, 14, 241.
Ay res 7. W., We idler D. J., MacKichan 7. et al. Pharmacokinetics of tolmetirj with and without concomitant administration of antacid in man. — Europ.. J. clin. Pharmacol., 1977, 12, 421.
Ay res 7. W., Weidler D. J., Sakmar E., Wagner 7. G. Linear and non-linear assessment of tolmetin pharmacokinetics. — Research Communications in* Chemical Pathology and Pharmacology, 1977, 17, 583.
Bernhard G. C, Poiley J., Tarpley E. L. A double-blind cooperative trial of tolmetin plus gold in the treatment of rheumatoid arthritis: in Ward (Ed.) Tolmetin: A New Non-steroidal Anti-inflammatory Agent, p. 108. Excerpta J^tedica Princeton 1975
Brogden Rl N., Heel k. C, Speight Т. M., Avery G. S. Tolmetin: A review of its pharmacological properties and therapeutic efficacy in rheumatic diseases. — Drugs, 1978, 15, 429.
Ehrlich G. E.f Roth S. Rheumatoid arthritis: Long-term therapy with tolmetin sodium. — Orthopaedics. Digest, 1976, 4, 16.
Ehrlich G. E. Tolmetin sodium. Meeting the clinical challenge; in Huskisson (Ed.) Clinics in Rheumatic Diseases, vol. 5. Anti-Rheumatic Drugs, p. 481. Saunders, London, 1979.
Huskisson E. C, Berry H., Scott J., Balme H. W. Tolectin for rheumatoid arthritis. — Rheumatol. Rehabilitation, 1974, 13, 132.
Plostnieks J., Cressman W. A., Lemanowicz E. F. et al. Human metabolism of tolmetin; in Ward (Ed.) Tolmetin: A New Non-steroidal Anti-inflammatory Agent, p. 22. Excerpta Medica, Princeton, 1975,
Robinson H., Abruzzo 7. L., Miyara A., Ward 7. R. Concommitant tolmetin and aspirin therapy in rheumatoid arthritis; in Ward (Ed.) Tolmetin: A New Non-steroidal Anti-inflammatory Agent, p. 88. Excerpta Medica, Princeton 1975.
Selley M. L., Thomas J., Triggs E. 7. A gas-liquid chromatographic method for the quantitative determination of tolmetin in plasma and tolmetin and its^ major metabolite in urine. — J. Chromatogr., 1974, 94, 143.
Selley M. L., Glass J., Triggs E. 7., Thomas 7. Pharmacokinetic studies of tolmetin in man. — Clin.Pharmacol. Therapeutics, 1975, 17, 599.
«Лечение ревматических заболеваний»,
под ред. Ф.Д.Харта